VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia
复制标题
VS38 染色有助于在流式细胞术中为小 B 细胞淋巴瘤(尤其是淋巴浆细胞淋巴瘤/华氏巨球蛋白血症)提供一种新的门控策略
DOI:
10.1002/cyto.b.22000
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Mitsumasa Watanabe
中科院分区:
文献类型:
--
作者:
Shumpei Mizuta;Noriko Yamane;Saya Mononobe;Asami Watanabe;Shinichiro Matsuki;Takao Komai;Yusuke Koba;Sachiko Mitani;Takahito Kawata;Akira Tamekane;Mitsumasa Watanabe
BackgroundMulti‐parametric flow cytometry (MFC) is a helpful tool for detecting neoplastic cells in malignant lymphoma; however, lymphoma cells can be difficult to detect when characteristic immunophenotypic abnormalities are not evident. We evaluated the stainability of VS38, which is used for multiple myeloma, in normal and abnormal B cells using MFC to develop a new strategy for detecting lymphoma cells.MethodsWe compared the median fluorescence intensity of VS38 staining in lymphocytes from patients without hematopoietic neoplasms and in B cells from 26 patients with B cell lymphoma (BCL). To evaluate the performance of VS38 gating, we compared VS38‐positive B cells with the percentages of BCL cells, and with the mutation ratios ofMYD88L265P measured by droplet digital PCR in patients with lymphoplasmacytic lymphoma (LPL)/Waldenström macroglobulinemia (WM).ResultsCD27‐positive memory B cells were stained with VS38, whereas normal lymphocytes were faintly stained. Lymphoma cells were stained with VS38 in 11 of 12 patients with LPL/WM, 3 of 3 with chronic lymphocytic leukemia, 3 of 5 with mantle cell lymphoma, 2 of 4 with follicular lymphoma, and 1 of 1 with splenic marginal zone lymphoma. The percentages of VS38‐positive B cells in VS38‐positive BCL were equivalent to those of lymphoma cells and the mutation ratios ofMYD88L265P in LPL/WM.ConclusionsVS38 identified neoplastic cells in plasma cell disorders and BCL. This might improve the accuracy of BCL diagnosis, especially in patients with LPL/WM.